Kindred Biosciences Inc (KIN) Return on Investment ROI from the second quarter of 2021 to second quarter of 2020 and for the year 2021, average high and low, overall ranking from Jun 30 2021 to Jun 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Kindred Biosciences Inc   (NASDAQ: KIN)


Kindred Biosciences Inc's ROI from its second quarter of 2021 to the second quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Kindred Biosciences Inc's ROI in the second quarter of 2021?
Kindred Biosciences Inc recorded a cumulative net loss of $-42 million during 12 months ending in the second quarter of 2021, resulting in a negative return on investment (ROI) of -43.12%.

Within the Healthcare sector 626 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2021 from 0 to 4241.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter
Y / Y Investment Change TTM -5.21 % -2.54 % -15.61 % -9.79 % -3.78 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 98 103 89 99 109
Return On Investment (TTM) -43.12 % -8.76 % -22.96 % -27 % -28.98 %
KIN's Overall Ranking # 4241 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -2.84 % 5.51 % -3.77 % -3.9 % -0.11 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -42 -9 -22 -27 -30

KIN Company Profile >> Back to KIN Roi Comparisons >> See Annual KIN Return On Investment



Return On Investment KIN's Ranking
Within: No.
Industry # 263
Sector # 627
Overall # 4241

Return On Investment Statistics
High Average Low
-8.76 %
-39.97 %
-66.27 %
(Mar 31 2021)   (Mar 31 2020)







Financial Statements
Kindred Biosciences Inc's II. Quarter Investments $ 98 Millions KIN's Balance sheet
Kindred Biosciences Inc's II. Quarter Income $ -9 Millions Quarterly KIN's Income Statement
KIN's Income by Division See KIN's Income by Division


KIN Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 89 104 91 85 58
Y / Y Investment Growth -14.34 % 13.69 % 7.67 % 46.94 % -24.48 %
Net Income in Millions -22 -61 -50 -31 -22
Y / Y Net Income Growth - - - - -
Annual Return On Investment -24.51 % -59.14 % -54.42 % -36.42 % -38.99 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
KIN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for KIN's Competitors
Subscribers only: Roi for Kindred Biosciences Inc's Suppliers
Subscribers only: Return On Investment for KIN's Customers

Other Ratios
KIN's Roa KIN's Inventory Turnover Ratio KIN's Growth Rates KIN's Dividend Statistics
KIN's Profitability Ratios KIN's Asset Turnover Ratio KIN's Dividend Growth
KIN's Roe KIN's Valuation Ratios KIN's Financial Strength Ratios KIN's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2021, within Healthcare Sector ROI

Date modified: 2026-08-29T17:19:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.